Schizophrenia.com
AbbVie Submits Cariprazine FDA Application for Major Depressive Disorder
Medications
everhopeful
February 22, 2022, 3:57pm
1
Related topics
Topic
Replies
Views
Activity
Otsuka and Lundbeck submit drug application to FDA
News
2
608
July 14, 2014
FDA Approves VRAYLAR as Adjunctive Therapy for Major Depressive Disorder and AbbVie Announces Reimbursement Program in Canada
Medications
0
230
June 7, 2023
FDA extends review of Allergan, Gedeon Richter's application for cariprazine
News
0
622
June 17, 2015
Cariprazine NDA resubmitted to FDA
News
0
453
January 9, 2015
Brexpiprazole - New Drug Application made today
News
0
580
July 15, 2014
